Stay updated on Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:22:22.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the enrollment number for the clinical trial involving nivolumab, ipilimumab, and short-course radiotherapy in adults with newly diagnosed, MGMT unmethylated glioblastoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:22:23.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying the required health conditions and prior treatments for participants. Previously, this section indicated that no information was provided.
    Difference
    57%
    Check dated 2024-05-22T20:30:36.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:39:58.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.